Frank Menzler
Corporate Officer/Principal bei Kruger Consulting, Inc.
Profil
Frank Menzler is President and Chief Executive Officer of Hepalife Technologies, Inc. and has been Chairman since June 11, 2008 and Interim Chief Financial Officer since November 17, 2008.
Mr. Menzler joined ABIOMED, Inc. in 2004 as General Manager-Europe and was named Director of International Distributors in 2006.
Prior to joining ABIOMED, he served as Marketing Manager for Europe, Middle East, Africa and Canada at Guidant Corporation's Cardiac Surgery Business Unit in Brussels, Belgium.
Prior to joining Guidant, Mr. Menzler co-founded Impella Cardiotechnik AG (Germany) in 1998.
Aktive Positionen von Frank Menzler
| Unternehmen | Position | Beginn |
|---|---|---|
Kruger Consulting, Inc.
 Kruger Consulting, Inc. Investment ManagersFinance Kruger Consulting, Inc. provides retirement services. The company is headquartered in Berea, OH. | Corporate Officer/Principal | 07.01.2010 |
Ehemalige bekannte Positionen von Frank Menzler
| Unternehmen | Position | Ende |
|---|---|---|
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Vorsitzender | 13.10.2009 |
| ABIOMED, INC. | Corporate Officer/Principal | - |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Vertrieb & Marketing | - |
Ausbildung von Frank Menzler
| Northwestern University | Masters Business Admin |
| RWTH Aachen University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Kruger Consulting, Inc.
Kruger Consulting, Inc. Investment ManagersFinance Kruger Consulting, Inc. provides retirement services. The company is headquartered in Berea, OH. | Finance |
